Hyderabad (Telangana) [India], May 28 (ANI): Indian Immunologicals Limited (IIL) has partnered with Hyderabad-based Bharat Biotech to manufacture drug substance for 'Covaxin' to ramp up the production of the COVID-19 vaccine.
New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
New Delhi [India], May 13 (ANI): Amid the reports of vaccine shortage from various state, Central government and Hyderabad based Bharat Biotech is willing to invite other companies who want to produce COVAXIN to increase the production, said NITI Aayog member, Dr VK Paul, on Thursday.
Hyderabad (Telangana) [India], April 24 (ANI): Covaxin, the indigenous vaccine against COVID-19 will be available for state governments at Rs 600 per dose and private hospitals at Rs 1,200 per dose, Hyderabad-based Bharat Biotech announced on Saturday.
Hyderabad (Telangana) [India], March 1 (ANI): French Ambassador to India Emmanuel Lenain on Monday visited Hyderabad-based Bharat Biotech and said that he was impressed by the company's commitment of making Covid-19 vaccine "a global public good, accessible and affordable throughout the worl
New Delhi [India], January 28 (ANI): India's drug regulatory body has received requests from both Pune based Serum Institute of India and Hyderabad-based Bharat Biotech to make necessary changes in the vaccine fact sheet to allow people using blood thinners to get inoculated against Covid-19
Bengaluru (Karnataka) [India], January 19 (ANI): After the Karnataka Association of Resident Doctors' objected to taking the Covaxin shot developed by Hyderabad-based Bharat Biotech and requested the government to use Covishield vaccine instead, Karnataka Health Minister Dr K Sudhakar on Tue
Hyderabad (Telangana) [India], December 22 (ANI): Hyderabad-based Bharat Biotech and US-based biopharmaceutical firm Ocugen Inc on Tuesday announced that they have signed a binding letter of intent (LOI) to co-develop the Indian firm's COVID-19 vaccine candidate--Covaxin-- for the United Sta
New Delhi [India], July 22 (ANI): Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine.
Hyderabad (Telangana) [India], June 30 (ANI): Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).